Keros Therapeutics KROS Q1 2025 earnings
Reported May 6, 2025 · Before market open
Revenue$211.2MBeat by $154.6M
EPS$3.62Beat by $3.63
Revenue estimate$56.6M
EPS estimate-$0.01
Next report
Aug 5, 2026 (In 1 week)Revenue estimate$807.1K
EPS estimate-$1.25
Versus estimates
Revenue
Diluted EPS
Ask the moment Keros Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Keros Therapeutics report Q1 2025 earnings?
- Keros Therapeutics (KROS) reported Q1 2025 earnings on May 6, 2025 before market open.
- What were Keros Therapeutics's Q1 2025 revenue and EPS?
- Keros Therapeutics reported revenue of $211.2M and eps of $3.62 for Q1 2025.
- Did Keros Therapeutics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $56.6M by $154.6M. EPS beat the consensus estimate of $-0.01 by $3.63.
- How did Keros Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 254413.3% from $83.0K a year earlier.
- Where can I find Keros Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001664710-25-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.